Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
Clinical trial NCT02403674 · COMPLETED
Trial details
- NCT number
- NCT02403674
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-05
- Primary completion
- 2017-03-20
- Enrollment
- 734
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.